IMIPENEM/CILASTATIN/ RELEBACTAM (Recarbrio®)

Clinical Indication

Aerobic Gram-negative infections

Date of classification

October 2020

Review date

July 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).